Project Grant R21AI187632
Award Date
9/26/24
Completion Date
8/31/26
Dollars Obligated
$226K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Davis, CA, USA
Similar Awards
This $2,002,422 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to advance the understanding of systemic and mucosal immunity to vaccination and infection with enteric bacterial pathogens like Salmonella and Shigella in children and adults. The research will use human-based models and specimens from clinical studies to examine the mechanisms underlying...
The University of Utah was awarded a $728,244 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct research on the molecular mechanisms of Salmonella's type III secretion system. The goal is to develop a better understanding of how this critical virulence mechanism in Gram-negative pathogens, including Salmonella, Shigella, Vibrio, Pseudomonas, Yersinia, and Chlamydia, selects...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $206,251 to Duke University to conduct research on the molecular mechanism and pathophysiology of robust STAT3 signaling during oral Salmonella Typhimurium infection. The research aims to elucidate how the Salmonella effector protein SARA hijacks and prolongs host STAT3 signaling to promote anti-inflammatory...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $7,105,240 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Davis. This 5-year grant, effective December 17, 2024, will support the development of an HIV vaccine regimen that elicits cooperative interactions between env fusion peptide-directed antibodies and follicle-homing helper and cytotoxic T cells. The grant program, titled "OPTIMAL T-CELL...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $204,347 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Vermont & State Agricultural College. The funding supports a 2-year research project to study the intracellular colonization strategies of Salmonella enterica serovar Typhimurium within human intestinal epithelial cells and macrophages. The researchers will use a combination of bacterial fluorescent...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,521,615 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Regents of the University of California, Berkeley (UC Berkeley). The grant, which runs from July 2024 to May 2029, supports research to engineer adjuvants - biomolecules that enhance immune responses to vaccine antigens. Specifically, the project aims to redesign the microbial biosynthetic pathway for the adjuvant...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $33,116,067 Cooperative Agreement to the University of California, Irvine (UCI) for the "Allergy and Infectious Diseases Research" program (CFDA 93.855). The award, titled "The UCI Vaccines for Pandemic Preparedness Center (VPPC)", aims to conduct basic and translational research to develop prototype vaccines against emerging viruses. The project will characterize and compare two universal,...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $569,210 Project Grant to the University of Colorado Boulder. The five-year grant, effective February 1, 2025, supports research to structurally and functionally characterize three proteins responsible for antimicrobial resistance, screen for probes to define inhibitory strategies, and develop a platform to quantitatively test the impact of target...
This federal Project Grant award, identified as R01AI189569, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award totaling $531,245.00 will fund research at Yale University focused on the structural and functional characterization of the sorting platform, a key component of the type III secretion system (T3SS) in Salmonella bacteria. Through a multidisciplinary approach involving...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the regulatory mechanisms controlling expression of a critical virulence system in the pathogen Salmonella Typhimurium. The $219,122 award to the University of Illinois will fund two primary research aims: 1) Investigating the regulation of small RNAs that control expression of the Salmonella...